McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
720.82
-1.01 (-0.14%)
At close: Jun 24, 2025, 4:00 PM
720.82
0.00 (0.00%)
After-hours: Jun 24, 2025, 4:10 PM EDT

Company Description

McKesson Corporation provides healthcare services in the United States and internationally.

It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International.

The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies.

The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services.

The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies.

The International segment delivers deliver medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers.

McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

McKesson Corporation
McKesson logo
Country United States
Founded 1833
Industry Medical Distribution
Sector Healthcare
Employees 51,000
CEO Brian Tyler

Contact Details

Address:
6555 State Highway 161
Irving, Texas 75039
United States
Phone 972 446 4800
Website mckesson.com

Stock Details

Ticker Symbol MCK
Exchange NYSE
Stock Type Common Stock
Fiscal Year April - March
Reporting Currency USD
CIK Code 0000927653
CUSIP Number 58155Q103
ISIN Number US58155Q1031
Employer ID 94-3207296
SIC Code 5122

Key Executives

Name Position
Brian S. Tyler Ph.D. Chief Executive Officer and Director
Britt J. Vitalone CPA Executive Vice President and Chief Financial Officer
Michele Lau J.D. Executive Vice President and Chief Legal Officer
LeAnn B. Smith Executive Vice President and Chief Human Resources Officer
Thomas L. Rodgers M.B.A. Executive Vice President and Chief Strategy and Business Development Officer
Napoleon B. Rutledge Jr. Senior Vice President, Controller and Chief Accounting Officer
Francisco Fraga Executive Vice President, Chief Information Officer and Chief Technology Officer
Jeni Dominguez Head of Investor Relations
Kirk Kaminsky President of The US Pharmaceutical and Specialty Solutions Business
Paul A. Smith Senior Vice President of Taxes

Latest SEC Filings

Date Type Title
Jun 20, 2025 ARS Filing
Jun 20, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 20, 2025 DEF 14A Other definitive proxy statements
Jun 9, 2025 8-K Current Report
Jun 6, 2025 144 Filing
May 30, 2025 144 Filing
May 30, 2025 8-K Current Report
May 30, 2025 SD Form - SD
May 28, 2025 144 Filing
May 28, 2025 144 Filing